Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 2Head & Neck 2Gynecologic 2Genitourinary 2Gastrointestinal 2Breast 2Sarcoma 1Plasma cell 1Other hematologic neoplasm 1Lymphoid 1Dermatologic 1CNS 1

Conditions

Sarcoma 10Sarcoma, Ewing 4Liposarcoma 4Rhabdomyosarcoma 3Rhabdoid Tumor 3Osteosarcoma 3Neuroblastoma 3Medulloblastoma 3Glioma 3Wilms Tumor 2Pancreatic Neoplasms 2Ovarian Neoplasms 2Neuroectodermal Tumors, Primitive, Peripheral 2Lymphoma, Non-Hodgkin 2Histiocytosis, Langerhans-Cell 2Hepatoblastoma 2Ependymoma 2Chordoma 2Breast Neoplasms 2Xanthogranuloma, Juvenile 1Urinary Bladder Neoplasms 1Recurrence 1Prostatic Neoplasms 1Neoplasms 1Neoplasm Metastasis 1Liposarcoma, Myxoid 1Histiocytic Sarcoma 1Head and Neck Neoplasms 1Gliosarcoma 1Glioblastoma 1

Interventions

pembrolizumab 3poly ICLC 2fludarabine 2belinostat 2aflibercept 2Radiosurgery 2Fluorodeoxyglucose F18 2Filgrastim 2Docetaxel 2Cyclophosphamide 2Carboplatin 2vocimagene amiretrorepvec 1tremelimumab 1trastuzumab deruxtecan 1seribantumab 1rucaparib 1romidepsin 1resiquimod 1palbociclib 1etoposide phosphate 1entinostat 1durvalumab 1ciforadenant 1cemiplimab 1cc-486 1avelumab 1amminedichloro(2-methylpyridine)platinum(II) 1Trastuzumab 1Thalidomide 1Taxes 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Urinary Bladder Neoplasms × palbociclib × Sarcoma × Clear all
NCT02897375 2023-10-10

Palbociclib With Cisplatin or Carboplatin in Advanced Solid Tumors

Emory University

Phase 1 Completed
71 enrolled
BreastGastrointestinalGenitourinaryGynecologicHead & NeckSarcomaThoracic

Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Head and Neck Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Sarcoma, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡